last updated: 2 months ago

last updated: 2 months ago

EnsoData logo

EnsoData

EnsoData

EnsoData

Empowering clinicians with #waveformAI 🍍

Empowering clinicians with #waveformAI 🍍

Hospitals and Health Care

Hospitals and Health Care

Madison

Madison

US

US

51–200 employees

51–200 employees

January 2015

January 2015

Overview

Overview

EnsoData uses Artificial Intelligence (AI) to unlock more rapid, accurate, and affordable diagnoses of the biggest threats to human health.

Over the past eight years, EnsoData has pioneered the clinical use and adoption of artificial intelligence (AI) and machine learning (ML) technology in sleep medicine (and healthcare more broadly) to solve large-scale problems at the heart of diagnosis and treatment decision-making.

EnsoData’s primary solution, EnsoSleep, was cleared by the FDA in 2017 to provide diagnostic analysis of in-lab sleep studies. EnsoSleep received expanded FDA clearance in 2021 to score and analyze home sleep studies, to add a viewing, editing, and reporting platform, and to record and output a total sleep time measurement.

The latest EnsoData AI algorithm, EnsoSleep PPG, was cleared by the FDA in February of 2024. EnsoSleep PPG turns the widely available and wearable FDA-cleared pulse oximetry technology into a diagnostic tool for clinicians.

This new clearance offers opportunities for clinicians to effectively reach patients by enabling AI-driven analysis using more accessible and cost-effective pulse oximeters.

Ultimately, our suite of AI tools help clinicians reduce healthcare turnaround times, cut into patient backlogs, and ultimately, improve the patient care journey and health outcomes.

EnsoData uses Artificial Intelligence (AI) to unlock more rapid, accurate, and affordable diagnoses of the biggest threats to human health.

Over the past eight years, EnsoData has pioneered the clinical use and adoption of artificial intelligence (AI) and machine learning (ML) technology in sleep medicine (and healthcare more broadly) to solve large-scale problems at the heart of diagnosis and treatment decision-making.

EnsoData’s primary solution, EnsoSleep, was cleared by the FDA in 2017 to provide diagnostic analysis of in-lab sleep studies. EnsoSleep received expanded FDA clearance in 2021 to score and analyze home sleep studies, to add a viewing, editing, and reporting platform, and to record and output a total sleep time measurement.

The latest EnsoData AI algorithm, EnsoSleep PPG, was cleared by the FDA in February of 2024. EnsoSleep PPG turns the widely available and wearable FDA-cleared pulse oximetry technology into a diagnostic tool for clinicians.

This new clearance offers opportunities for clinicians to effectively reach patients by enabling AI-driven analysis using more accessible and cost-effective pulse oximeters.

Ultimately, our suite of AI tools help clinicians reduce healthcare turnaround times, cut into patient backlogs, and ultimately, improve the patient care journey and health outcomes.

Key personnel profiles

Key personnel profiles

Key personnelS

Chris Fernandez

Executive Chairman & Chief Research Officer at EnsoData

view profile

Sam Rusk

Co-founder/CAIO at EnsoData

view profile

Nick Glattard

Co-founder, CTO, data philosopher at EnsoData

view profile

Justin Mortara, Ph.D.

CEO | Physicist | Investor | Dreaming no small dreams!

view profile

Hiring Trend

Hiring Trend

TOTAL hires

TOTAL hires

11

11

APR'26JUN'26JUL'26AUG'26SEP'26
APR'26JUN'26JUL'26AUG'26SEP'26

Employee Growth

Employee Growth

TOTAL EMPLOYEES

TOTAL EMPLOYEES

91

91

6m GROWTH

6m GROWTH

10%

10%

1y GROWTH

1y GROWTH

23%

23%

NOV'25DEC'25JAN'26FEB'26MAR'26APR'26MAY'26JUN'26JUL'26AUG'26SEP'26OCT'26
NOV'25DEC'25JAN'26FEB'26MAR'26APR'26MAY'26JUN'26JUL'26AUG'26SEP'26OCT'26

Employee Distribution & Department Growth

Employee Distribution & Department Growth

TOTAL EMPLOYEES

TOTAL EMPLOYEES

91

91

6m GROWTH

6m GROWTH

1y GROWTH

1y GROWTH

Department distribution

Department distribution

Department distribution

DEPARTMENT

6m GROWTH

1y GROWTH

Engineering

Engineering

Engineering

9%

9%

9%

32%

32%

32%

Sales

Sales

Sales

-5%

-5%

-5%

40%

40%

40%

Information Technology

Information Technology

Information Technology

125%

125%

125%

200%

200%

200%

Business Development

Business Development

Business Development

0%

0%

0%

0%

0%

0%

Operations

Operations

Operations

-17%

-17%

-17%

-29%

-29%

-29%

Web Engagement

pages per visit

pages per visit

5

5

monthly visits

monthly visits

8,677

8,677

JUL'26AUG'26SEP'26
JUL'26AUG'26SEP'26

Web Traffic by Country

Web Traffic by Country

United States

89.5%

United States

89.5%

India

10.5%

India

10.5%

Web Traffic Sources

Web Traffic Sources

monthly visits

8,677

Direct

30.2%

Direct

30.2%

Search

29.8%

Search

29.8%

Social

3%

Social

3%

Referrals

6.5%

Referrals

6.5%

AI

0.8%

AI

0.8%

funding round

funding round

2

total funding raised

total funding raised

$50M

last round type

last round type

Series B

last round amount

last round amount

$20M

announced on

announced on

$20M

funding round

2

total funding raised

$50M

last round type

Series B

last round amount

$20M

announced on

$20M

lead investors

lead investors

lead investors

Questa Capital, Zetta Venture Partners, Venture Investors Health Fund, Supermoon Capital, Inspire Medical Systems

Questa Capital, Zetta Venture Partners, Venture Investors Health Fund, Supermoon Capital, Inspire Medical Systems

Recent News & Articles

Recent News & Articles

A network graph of your entire TAM. We find the path into every account worth a meeting, and book it.

Powered by NVIDIA and AWS.

RESOURCES

Made with love.

© 2026 InGrow. All rights reserved.

A network graph of your entire TAM. We find the path into every account worth a meeting, and book it.

Powered by NVIDIA and AWS.

RESOURCES

Made with love.

© 2026 InGrow. All rights reserved.

A network graph of your entire TAM. We find the path into every account worth a meeting, and book it.

Powered by NVIDIA and AWS.

RESOURCES

Made with love.

© 2026 InGrow. All rights reserved.

A network graph of your entire TAM. We find the path into every account worth a meeting, and book it.

Powered by NVIDIA and AWS.

RESOURCES

Made with love.

© 2026 InGrow. All rights reserved.